Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredients Lamivudine, Tenofovir Disoproxil And Doravirine (J05Ar24) As Part Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 80942209

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredients lamivudine, tenofovir disoproxil and doravirine (J05AR24) within the pe riod from June 1st, 2024 to May 31st, 2026 with the possibility of concluding the contract at any time (open -house model). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (childrens medicines) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Lamivudin, Tenofovirdisoproxil und Doravirin (J05A

Gt Ref Id - 80942209

Deadline - Mar 31, 2026